A postgraduate research opportunity at the University of Otago.
- Academic background
- Health Sciences
- Host campus
- Postgraduate Diploma, Honours, Master’s
- Pathology (Dunedin)
- Dr Cath Drummond, Dr Glen Reid
Cancer treatment has been revolutionised by therapies which act by specifically blocking the pathways that drive cancer.
However, despite initial dramatic results, relapse is inevitable and a major clinical problem.
Recent studies have identified a rare population of drug-tolerant cells as being largely responsible for relapse. These cells evade therapy by changing their identity during the course of treatment, thus surviving to repopulate the tumour.
This project involves using cellular and molecular biology to understand how drug-tolerant cells evade therapy to survive treatment.